Skip to main content

In the News

FDA Approvals, In the News
April 16, 2019 – FDA Approvals, News & Updates
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness
Read More
FDA Approvals, In the News, Lung Cancer, Oncology
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Read More
FDA Approvals, In the News
March 08, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
FDA Approves Pembrolizumab for Treatment of Advanced Melanoma
Read More
FDA Approvals, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
FDA Approvals, In the News
February 1, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
Page 3 of 7
Results 21 - 30 of 62